Proto Labs: Restructuring Costs Pose A Short-Term Headwind (Downgrade)

2026-05-17 02:50:57 ET

Thesis Review

Since my previous coverage on Proto Labs ( PRLB ), the stock has outperformed the broader market, returning 49% vs. the 16.24% of the S&P 500. If you look carefully at the price trend, you'll realize that most of these returns occurred in the beginning of this year. From the time my article was published to the end of Q4 2025, the stock was pretty much trending sideways, even though revenue growth, especially from the CNC machining segment, started to show massive improvements throughout 2025. The bear case for Proto has always been the margin compression the firm has been experiencing since 2016. So even though the revenue growth started ticking up a bit, due to the manufacturing demand coming from the defense and aerospace industries, the market wasn't fully convinced the growth would trickle down to the bottom line and expand margins. During the release of Q4 earnings results , the firm showed full-year topline growth of 6% and net income growth of 33%, reflecting strong growth from the CNC segment and net margin improvement. As a result, the stock appreciated by more than 15% in a single day. The recent growth in the bottom line was largely driven by a favorable revenue mix and slightly offset by the restructuring costs associated with the European reset. The current valuation doesn't give me enough confidence for further upside, and given the ongoing restructuring, margins could contract a bit in the short term, increasing drawdown risks; as a result, I'm downgrading Proto to a hold....

Read the full article on Seeking Alpha

For further details see: